- Home
- INMB vs JYNT Comparison
INMB vs JYNT Comparison
Compare INMB & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- JYNT
- Stock Information
- Founded
- INMB 2015
- JYNT 2010
- Country
- INMB United States
- JYNT United States
- Employees
- INMB N/A
- JYNT N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- JYNT Multi-Sector Companies
- Sector
- INMB Health Care
- JYNT Miscellaneous
- Exchange
- INMB Nasdaq
- JYNT Nasdaq
- Market Cap
- INMB 176.5M
- JYNT 170.1M
- IPO Year
- INMB 2019
- JYNT 2014
- Fundamental
- Price
- INMB $7.09
- JYNT $10.53
- Analyst Decision
- INMB Strong Buy
- JYNT Strong Buy
- Analyst Count
- INMB 3
- JYNT 1
- Target Price
- INMB $24.33
- JYNT $15.00
- AVG Volume (30 Days)
- INMB 225.9K
- JYNT 60.7K
- Earning Date
- INMB 05-08-2025
- JYNT 05-08-2025
- Dividend Yield
- INMB N/A
- JYNT N/A
- EPS Growth
- INMB N/A
- JYNT N/A
- EPS
- INMB N/A
- JYNT N/A
- Revenue
- INMB $14,000.00
- JYNT $51,896,605.00
- Revenue This Year
- INMB N/A
- JYNT $10.88
- Revenue Next Year
- INMB N/A
- JYNT $12.11
- P/E Ratio
- INMB N/A
- JYNT N/A
- Revenue Growth
- INMB N/A
- JYNT 10.47
- 52 Week Low
- INMB $4.32
- JYNT $9.58
- 52 Week High
- INMB $11.76
- JYNT $17.82
- Technical
- Relative Strength Index (RSI)
- INMB 41.97
- JYNT 51.23
- Support Level
- INMB $6.98
- JYNT $9.61
- Resistance Level
- INMB $8.00
- JYNT $10.57
- Average True Range (ATR)
- INMB 0.45
- JYNT 0.51
- MACD
- INMB -0.06
- JYNT 0.07
- Stochastic Oscillator
- INMB 6.51
- JYNT 71.10
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.